FI
FRTX

Fosun International’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Fosun International’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-994
Closed -$265K – 300
2019
Q2 		$265K Buy
+994
New +$333K 0.02% 265

Other funds holding FRTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fosun International's FRTX Position: Q3 2019 in Review

Fosun International sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2019, closing a stake of 994 shares — an estimated $265K sold.

Fosun International first reported a position in FRTX in Q2 2019 and held it in 1 quarter. The position peaked at $265K in Q2 2019. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2019.

  • Fosun International reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 994 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $265K.
  • Fosun International first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Fosun International's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $265K in Q2 2019.
  • 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.